ICT announces $28.3M series B round

Innovative Cellular Therapeutics Co. Ltd. (Shanghai, China) raised RMB180 million ($28.3 million) in a

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE